(Q83660023)

English

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

scientific article published on 01 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rocío García-Carbonero

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Cristina Grávalos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Carlos Gómez-Martín

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Fernando Rivera

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Inmaculada Alés

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Bernardo Queralt

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Antonia Márquez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ulpiano Jiménez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Vicente Alonso

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Javier Sastre

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hernán Cortés-Funes

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Antonio Jimeno

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

179-184

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21421462%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

https://scigraph.springernature.com/pub.10.1007/s12094-011-0637-6

0 references

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric cancer epidemiology and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu and breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21421462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83660023&oldid=1743752342"